Loading…
Hosted by CytoReason · 🇺🇸 US · EN · 13 episodes
Established thought leaders with verified media credentials.
In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials. It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.
CytoReason hosts Tech on Drugs with Shai Shen-Orr, a technology show with 13 episodes published.
In this special episode, we are sharing a conversation from the NVIDIA AI Podcast, hosted by Noah Kravitz, featuring our host Shai Shen-Orr. The discussion dives into CytoReason’s partnership with NVIDIA and how computat
What happens when two leading computational biologists swap code and models for a lively conversation? Fabian Theis, a pioneer in single-cell and AI-driven biomedical research, joins Shai for a fascinating exchange about
What happens when two leading computational biologists swap code and models for a lively conversation? Prof. Fabian Theis — Director of the Computational Health Center at Helmholtz Munich, a pioneer in single-cell and AI
We’re kicking off Season 3 of Tech on Drugs with Prof. Nir Hacohen — Director of the Center for Cancer Research at MGH, founding director of the Broad Institute’s Cell Circuits Program, and a distinguished member of Cyto
Tom Bumol's career spans major roles at Eli Lilly, the Allen Institute, and beyond. He is also a distinguished member of CytoReason's Science Advisory Board.In this episode, Tom shares insights into drug development's su
This episode was recorded in the beautiful Island of Crete, at CytoReason's employee conference, the CytoSummit. CytoReason's Co-founder Shai Shen-Orr hosts AION Labs CTO Yair Benita. Yair is a computational biologist wh
While most neuroimmunologists try to understand how the immune system affects the brain, Prof. Asya Rolls has taken the road less traveled in her lab at the Technion. She and her team try to understand how the brain affe
This one was fun. In the latest episode of Tech on Drugs, Shai met with Prof. Eran Segal from the Weizmann Institute of Science. Eran heads a multidisciplinary team of computational biologists and experimental scientists
Our guest this time was Prof. Ido Amit, whose lab at the Weizmann Institute of Science pioneered single cell transcriptomic analysis and its application to the immune system. Amit’s research focuses on some of the most i
What will the future of precision medicine look like 5-10 years down the line? And how will AI accelerate this future? I asked Dr. Emanuele de Rinaldis to answer this and many other questions. Emanuele is VP, Global Head
Our guest this time is serial biotech entrepreneur Yanay Ofran. Yanay is a renowned computational biophysicist and the CEO and Co-founder of Biolojic Design. More importantly, Yanay, together with his stellar team, devel
The doctor in the clinic must build on molecular features and the bioinformatician in the lab must build on data from the clinic. Prof. Yehuda Chowers, a leading gastroenterologist, has been harping on this point for yea
Our first episode features world renowned epidemiologist, Prof. Ran Balicer, Chief Innovation Officer at Clalit Health Services, Israel’s largest healthcare organization. We talked about the mining of real-world data and
This is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials. In each episode, our host Prof. Shai Shen-Orr talk
Shai Shen-Orr
CytoReason
1 appearance on this show
Prof. Fabian Theis
Helmholtz Munich
1 appearance on this show
Prof. Shai Shen-Orr
CytoReason
1 appearance on this show
Nir Hacohen
Center for Cancer Research at MGH
1 appearance on this show
Yair Benita
CytoReason
1 appearance on this show
Prof. Asya Rolls
Technion
1 appearance on this show
Eran Segal
Weizmann Institute of Science
1 appearance on this show
Prof. Ido Amit
Weizmann Institute of Science
1 appearance on this show
Dr. Emanuele de Rinaldis
Sanofi
1 appearance on this show
Yanay Ofran
Biolojic Design
1 appearance on this show
Ran Balicer
Clalit Health Services
1 appearance on this show
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Tech on Drugs with Shai Shen-Orr has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their technology audience.
Tech on Drugs with Shai Shen-Orr is hosted by CytoReason. The show is categorised under technology and has published 13 episodes.
Tech on Drugs with Shai Shen-Orr has published 13 episodes.
Tech on Drugs with Shai Shen-Orr regularly covers technology. It sits in the technology category.
Tech on Drugs with Shai Shen-Orr is accessible for guests with genuine technology expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Tech on Drugs with Shai Shen-Orr hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Tech on Drugs with Shai Shen-Orr average 30 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Tech on Drugs with Shai Shen-Orr's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 4 days ago.